VALYSTR · Stock research
Listed on NYSE. What the market is pricing into Revvity, Inc. (RVTY) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Diagnostics & Research · market value about $18.2B · P/E 78.2 · revenue $2.9B (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows